York Charles N II's Form 4 filing
Day One Biopharmaceuticals, Inc. (DAWN) · filed Feb 21, 2025
- Accession no.
- 0001415889-25-005159
- Filed
- Feb 21, 2025
- Trade date
- Feb 15-18, 2025
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $52.3K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| York Charles N IICIK 0001655962 | Officer (COO, CFO AND SECRETARY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2025 | Common Stock | MOption exerciseAcquired | +1,375 | – | – | 241,508 | Direct | |
| Feb 15, 2025 | Common Stock | MOption exerciseAcquired | +2,250 | – | – | 243,758 | Direct | |
| Feb 15, 2025 | Common Stock | MOption exerciseAcquired | +6,625 | – | – | 250,383 | Direct | |
| Feb 15, 2025 | Common Stock | MOption exerciseAcquired | +6,625 | – | – | 257,008 | Direct | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −4,370 | $11.96 | −$52,265.2 | 252,638 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2025 | Common Stock | MOption exerciseDisposed | −1,375 | $0.00 | $0 | 4,125 | Direct | |
| Feb 15, 2025 | Common Stock | MOption exerciseDisposed | −2,250 | $0.00 | $0 | 15,750 | Direct | |
| Feb 15, 2025 | Common Stock | MOption exerciseDisposed | −6,625 | $0.00 | $0 | 72,875 | Direct | |
| Feb 15, 2025 | Common Stock | MOption exerciseDisposed | −6,625 | $0.00 | $0 | 99,375 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.